Ben Ayed N, Gargouri O, Mhimdi S, Smaoui F, Mhiri E, Kanzari L
Antibiotics (Basel). 2025; 14(2).
PMID: 40001415
PMC: 11851641.
DOI: 10.3390/antibiotics14020171.
Silva-Pinto A, Abreu I, Martins A, Bastos J, Araujo J, Pinto R
Vaccines (Basel). 2025; 12(12.
PMID: 39772108
PMC: 11680230.
DOI: 10.3390/vaccines12121449.
Civljak R, Drazenovic K, Butic I, Kljakovic Gaspic Batinjan M, Huljev E, Vickovic N
Front Public Health. 2024; 12:1480348.
PMID: 39697284
PMC: 11652491.
DOI: 10.3389/fpubh.2024.1480348.
Nasreen S, Wang J, Marra F, Kwong J, McGeer A, Sadarangani M
Thorax. 2024; 79(9):861-869.
PMID: 38359926
PMC: 11347212.
DOI: 10.1136/thorax-2023-220377.
Teixeira R, Kossyvaki V, Galvez P, Mendez C
Microorganisms. 2023; 11(6).
PMID: 37374878
PMC: 10303156.
DOI: 10.3390/microorganisms11061376.
Economic and cost-effectiveness aspects of vaccines in combating antibiotic resistance.
Yemeke T, Chen H, Ozawa S
Hum Vaccin Immunother. 2023; 19(1):2215149.
PMID: 37248971
PMC: 10231042.
DOI: 10.1080/21645515.2023.2215149.
The Molecular Epidemiology of Pneumococcal Strains Isolated from the Nasopharynx of Preschool Children 3 Years after the Introduction of the PCV Vaccination Program in Poland.
Kielbik K, Grywalska E, Glowniak A, Mielnik-Niedzielska G, Korona-Glowniak I
Int J Mol Sci. 2023; 24(9).
PMID: 37175589
PMC: 10178342.
DOI: 10.3390/ijms24097883.
Antibiotic Resistance of in the Nasopharynx of Healthy Children Less than Five Years Old after the Generalization of Pneumococcal Vaccination in Marrakesh, Morocco.
Amari S, Warda K, Bouraddane M, Katfy M, Elkamouni Y, Arsalane L
Antibiotics (Basel). 2023; 12(3).
PMID: 36978307
PMC: 10044557.
DOI: 10.3390/antibiotics12030442.
The impact of the introduction of ten- or thirteen-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal disease and carriage: A systematic literature review.
Reyburn R, Maher J, von Mollendorf C, Gwee A, Mulholland K, Russell F
J Glob Health. 2023; 13:05001.
PMID: 36799235
PMC: 9936452.
DOI: 10.7189/jogh.13.05001.
Molecular Characterization and Antibiotic Susceptibility of Non-PCV13 Pneumococcal Serotypes among Vaccinated Children in Cape Coast, Ghana.
Mills R, Abdullah M, Akwetey S, Sappor D, Bolivar J, Gamez G
Microorganisms. 2022; 10(10).
PMID: 36296330
PMC: 9609747.
DOI: 10.3390/microorganisms10102054.
Impact of Pneumococcal Vaccination on Nasopharyngeal Carriage of and Microbiota Profiles in Preschool Children in South East Poland.
Kielbik K, Pietras A, Jablonska J, Bakiera A, Borek A, Niedzielska G
Vaccines (Basel). 2022; 10(5).
PMID: 35632547
PMC: 9143411.
DOI: 10.3390/vaccines10050791.
Streptococcus pneumoniae colonization in health care professionals at a tertiary university pediatric hospital.
Steurer L, Hetzmannseder M, Willinger B, Starzengruber P, Mikula-Pratschke C, Kormann-Klement A
Eur J Clin Microbiol Infect Dis. 2022; 41(6):971-976.
PMID: 35469365
PMC: 9135860.
DOI: 10.1007/s10096-022-04446-z.
Antibiotic Susceptibility of and Isolates from the Nasopharynx of Febrile Children under 5 Years in Nanoro, Burkina Faso.
Bonko M, Lompo P, Tahita M, Kiemde F, Karama I, Some A
Antibiotics (Basel). 2021; 10(4).
PMID: 33920987
PMC: 8071235.
DOI: 10.3390/antibiotics10040444.
A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents: , , and .
Tsang R
Microorganisms. 2021; 9(2).
PMID: 33671611
PMC: 7926440.
DOI: 10.3390/microorganisms9020449.
A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age.
Essink B, Peterson J, Yacisin K, Lal H, Mirza S, Xu X
Hum Vaccin Immunother. 2021; 17(8):2691-2699.
PMID: 33661716
PMC: 8475590.
DOI: 10.1080/21645515.2021.1890511.
A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States.
Fitz-Patrick D, Young Jr M, Scott D, Scully I, Baugher G, Peng Y
Hum Vaccin Immunother. 2021; 17(7):2249-2256.
PMID: 33545022
PMC: 8189073.
DOI: 10.1080/21645515.2020.1863177.
Signs and symptoms do not predict, but may help rule out acute Q fever in favour of other respiratory tract infections, and reduce antibiotics overuse in primary care.
Hackert V, Dukers-Muijrers N, Hoebe C
BMC Infect Dis. 2020; 20(1):690.
PMID: 32957938
PMC: 7503428.
DOI: 10.1186/s12879-020-05400-0.
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
Hurley D, Griffin C, Young M, Scott D, Pride M, Scully I
Clin Infect Dis. 2020; 73(7):e1489-e1497.
PMID: 32716500
PMC: 8492133.
DOI: 10.1093/cid/ciaa1045.
Population structure across scales facilitates coexistence and spatial heterogeneity of antibiotic-resistant infections.
Krieger M, Denison C, Anderson T, Nowak M, Hill A
PLoS Comput Biol. 2020; 16(7):e1008010.
PMID: 32628660
PMC: 7365476.
DOI: 10.1371/journal.pcbi.1008010.
Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland.
Hjalmarsdottir M, Haraldsson G, Quirk S, Haraldsson A, Erlendsdottir H, Kristinsson K
PLoS One. 2020; 15(3):e0230332.
PMID: 32182260
PMC: 7077842.
DOI: 10.1371/journal.pone.0230332.